Impaza tablets for resorption , # 20

Impaza tab.

d / rass No. 20

Name ENG

IMPAZA

Clinical and pharmacological group

Drug for the treatment of erectile dysfunction

ATX code

Drugs for the treatment of erectile dysfunction

Dosage

3mg

Structure

Active components: antibodies to endothelial NO synthase affinity purified - 0, 003

d *. Excipients: lactose, microcrystalline cellulose, magnesium stearate.

* introduced in the form of a water-alcohol mixture of the active form of the active substance 1

The active form of the active substance is the active form with a content of not more than 10-15 ng / g of the active substance.

Indications

Erectile dysfunction (erectile dysfunction) of various origins.

Vegetative disorders of menopause in men (weakness, fatigue, decreased physical activity, decreased libido, etc.).

INN / Active ingredient

Antibodies to endothelial NO synthase affinity purified

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Contraindications

Increased individual sensitivity to drug components

age up to 18 years

lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

Specifications

Category

BPH

,

Impotence in men

Scope of the drug

Genitourinary system

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

twenty

Scope of application

Urology

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Materia Medica Holding

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Erectile Dysfunction Treatment

Anatomical and therapeutic characteristics

G04BE Drugs for the treatment of erectile dysfunction

Dosage form

Lozenges

Expiration date in days

1095

Package weight, g

twenty

Mode of application

:

At a time - 1 tablet (keep in the mouth until completely dissolved - not during meals). < br> Regular intake.

To stabilize sexual potency (ability to have sexual intercourse), a therapeutic and prophylactic course of at least 12 weeks is recommended.

Depending on the severity.

Dosage (volume) of the substance in the preparation

:

antibodies to endothelial NO synthase affinity purified 0.003 g